14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 53 days ( 0 % )
Last Price $31.23 0 %
High/ Low $31.23 - $31.23 0%
Chg 7 Days N/A $31.23 $31.23
Chg 30 Days N/A $31.23 $31.23
Chg 12 mos 658.01 % $4.12 $31.23
Trend - 3 mos 4.66 % Width: 4.94 %
Trend - 12 mos 130.66 % Width: 66.92 %
Pred. range - 3 mos $31.97 - $33.55 2.38 % - 7.44 %
Pred. range - 12 mos $54.71 - $91.32 75.18 % - 192.41 %
Short MA avg 3 mos Buy Feb 05, 2024 - 56 days
Long MA avg 3 mos Buy Feb 07, 2024 - 54 days
Short/Long MA avg 3 mos Buy Feb 07, 2024 - 54 days
Short MA avg 12 mos Buy Feb 06, 2024 - 55 days
Long MA avg 12 mos Buy Nov 21, 2023 - 106 days
Short/Long MA avg 12 mos Buy Nov 29, 2023 - 101 days
Pivot Short Sell Apr 23, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT